Regulatory considerations for both preapproval and postapproval studies. Highlighting early engagement with the FDA at the study design stage.
Updates
Research must recognize and explore the multiple drivers of people’s healthcare experiences and outcomes to address inequity.
Article contributed by Naoko Ronquest (she/her), PhD, Executive Director, US HTA Strategy and Early Modeling
The award recognizes RTI’s commitment to providing a positive work environment and creating a culture of belonging
Guideline-Based Treatment Offers Greater Survival for Older Patients with Metastatic Breast Cancer
Medullary thyroid cancer (MTC) is a rare cancer, generally diagnosed at early stages of the disease when prognosis is favorable. Mutations in the RET gene are involved in the development of the cancer and are common in patients with MTC.
Meningococcal disease is caused by the bacterium Neisseria meningitidis and can have serious, life-threatening outcomes. Two types of vaccines are recommended for adolescents and young adults in the United States (US) to protect against meningococcal serotypes ACWY (MenACWY) and B (MenB).
Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and well-being of its employees through a workplace wellness program.
Acromegaly Symptom Diary Acromegaly is a rare but serious condition caused by pituitary tumors that result in overabundance of growth hormone and insulin-like growth factor-1. This hormonal excess results in tissue growth, including changes to facial features.
Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall survival rates for patients with NSCLC with brain metastases are low.
Traumatic brain injury (TBI) is an alteration in brain function caused by an external force. TBI of so-called mild severity (mTBI) represents 70-90% of cases and is a frequent cause of emergency department visits.
A group of RTI Health Solutions researchers was recently recognized by the wider RTI organization for their contributions to a body of research.
Research coauthored by RTI Health Solutions researchers will be presented at the 2023 Respiratory Synctial Virus Foundation.
Dr. Stephanie Earnshaw, PhD, Senior Vice President, Health Economics at RTI Health Solutions, named a North Carolina State University (NCSU) Distinguished Alumnus, Class of 2022.
Josephine (Jo) Mauskopf, PhD, MHA, Vice President of Health Economics at RTI Health Solutions, has been appointed as a Distinguished Fellow at RTI International.
New Research on the Public Health and Economic Benefits of Pediatric Immunization in the US Two studies just published in Pediatrics give us an updated picture of how well childhood immunizations prevent disease and the economic impact of this disease prevention.
Christine Barnett, PhD, Associate Director of Health Economics at RTI Health Solutions, proudly announces publication of Artificial Intelligence for Healthcare: Interdisciplinary Partnerships for Analytics-Driven Improvements in a Post-
RTI International, parent company of RTI Health Solutions, has been named among Forbes’ Best Employers for Women.
Top-scorers demonstrated commitment to disability inclusion and equality RTI International, a nonprofit research institute and parent company of RTI Health Solutions, has
Despite recent advances in the treatment of psoriatic arthritis (PsA), for some who live with the condition, available treatments do not supply adequate relief for their most troublesome symptoms. To help improve lives, new treatments need to address these unmet needs.
Learn more about the award-winning presentation along with our full list of RTI-HS contributions to ISPOR 2022.
Bradley, who has been a member of ISPE since 2011, was recommended for this honor by a committee of his peers
Andrea Margulis, MD, ScD, FISPE, Epidemiology Director at RTI Health Solutions, elected to the International Society for Pharmacoepidemiology (ISPE) Board of Directors.
The recognition honors companies demonstrating exceptional leadership and a commitment to business integrity through best-in-class ethics, compliance, and governance practices
Guidance Expanded to Reflect Developments in Reporting Economic Evaluations of Health Interventions